SAN DIEGO (AP) — SAN DIEGO (AP) — Gossamer Bio Inc. (GOSS) on Tuesday reported a loss of $47.2 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of 21 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.

The biopharmaceutical company posted revenue of $13.8 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $7.6 million.

For the year, the company reported a loss of $170.4 million, or 75 cents per share. Revenue was reported as $48.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GOSS at https://www.zacks.com/ap/GOSS